CIK 0001599298 · Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 371979717
- Phone
- 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- 8-K Event Executive or director change
- 8-K Event Shareholder vote results
- CT ORDER Other Confidential Order
- DEFA14A Proxy Proxy Materials
- 8-K Event Executive or director change
- 8-K Event Auditor change
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Executive or director change
- DEF 14A Proxy Proxy Statement
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Other events
- 424B4 Offering Prospectus
- 10-K Report Annual Report
- SC 13D/A Stake Beneficial Ownership Report
Page 16 of 29 · 564 filings